Beranda › Leukemia-Limfoma Limfoblastik Sel T Prekursor › Texas
Uji klinis Leukemia-Limfoma Limfoblastik Sel T Prekursor di Texas
8 studi untuk Leukemia-Limfoma Limfoblastik Sel T Prekursor mencari peserta di lokasi di Texas.
Kota di Texas
Teks studi resmi (Bahasa Inggris)
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy in T-Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- MD Anderson Cancer Center, Houston
- Sarah Cannon Transplant and Cellular Therapy Methodist Hospital, San Antonio
Menerima pesertaFase 2
6 Months · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT06514794A Phase 2 Study to Evaluate Efficacy of Calaspargase Pegol-mknl and Decitabine Combined With Venetoclax in Pediatric, Adolescent, and Young Adult Patients With Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia (T-ALL) and T- Cell Lymphoblastic Lymphoma (T-LLy)
- MD Anderson Cancer Center, Houston
Menerima pesertaFase 2
1 Month – 21 Years · Semua jenis kelamin · Diperbarui 18 Sep 2026 · NCT06561074Targeted Immunotherapy After Myeloablative TBI-Based Conditioning & AlloHCT in CAYA With High Risk T-Cell ALL & Lymphoma
- MD Anderson Cancer Center, Houston
Menerima pesertaFase 1
Hingga usia 39 · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT04972942Venetoclax, Dexamethasone, Bortezomib, and Daratumumab For The Treatment Of Adolescent And Young Adults With Relapsed Or Refractory T-Cell Acute Lymphoblastic Leukemia And T-cell Acute Lymphoblastic Lymphoma
- UT MD Anderson, Houston
Menerima pesertaFase 1
Usia 12 hingga 30 · Semua jenis kelamin · Diperbarui 12 Agu 2026 · NCT07513129Autologous T-Cells Expressing a Second Generation CAR for Treatment of T-Cell Malignancies Expressing CD5 Antigen
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Menerima pesertaFase 1
Hingga usia 75 · Semua jenis kelamin · Diperbarui 11 Agu 2026 · NCT03081910Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- M D Anderson Cancer Center, Houston
Menerima pesertaFase 2
Semua usia · Semua jenis kelamin · Diperbarui 15 Jul 2026 · NCT00501826A Registry for People With T-cell Lymphoma
- MD Anderson Cancer Center (Data Collection Only), Houston
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 20 Mei 2026 · NCT05978141Novel Unedited Allo Cell Therapy For High Risk T-Cell Malignancies Using CD7-Specific Car T Cells
- Houston Methodist Hospital, Houston
- Texas Children's Hospital, Houston
Menerima pesertaFase 1
Hingga usia 75 · Semua jenis kelamin · Diperbarui 18 Mei 2026 · NCT07220993Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.